2[2]Cuoco MA,Pereira AC,de Freitas HF,et al.Angiotensin converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure[J].Int J Cardiol,2005,99(1):97-103.
3[3]Goldbergova M,Spinarova L,Spinar J,et al.Association of two angiotensinogen gene poly-morphisms,M235T and G(6)A,with chronic heart failure[J].Int J Cardiol,2003,89(2-3):267-272.
4[4]Hindorff LA,Heckbert SR,Tracy R,et al.Angiotensin Ⅱ type 1 receptor polymorphisms in the cardiovascular health study:relation to blood pressure,ethnicity,and cardiovascular events[J].Am J Hypertens,2002,15(12):1050-1056.
5[5]Andersson B,Blange I,Sylven C.Angiotensin-Ⅱ type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure[J].Eur J Heart Fail,1999,1 (4):363-369.
6[6]Cicoira M,Zanolla L,Rossi A,et al.Failure of aldosterone suppression despite angiotesin converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype[J].J Am Coll Cardiol,2001,37(7):1808-1812.
7[7]Cicoira M,Rossi A,Bonapace S,et al.Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure[J].Am J Med,2004,116(10):657-661.
9[9]McNamara DM,Holubkov R,Postava L,et al.Pharmacoge netic interactions between angi-otensin-converting enzyme inhibitor therapy and the angiotensin converting enzyme deletion polymorphism in patients with congestive heart failure[J].J Am Coll Cardiol,2004,4(10):2019-2026.
10[10]de Groote P,Helbecque N,Lamblin N,et al.Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure[J].Eur J Heart Fail,2004,6(1):17-21.
二级参考文献17
1Bristow MR. Why does the myocardium fail? insights from basic science.Lancet, 1998, 352 (suppl Ⅰ): S14-S18.
2Green SA, Turki J, Innis M, et al. Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry, 1994, 33: 9414-9419.
3Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol, 1993, 8: 334-339.
4Green SA, Cole G, Jacinto M, et al. A polymorphism of the human β2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptos. J Biol Chem, 1993,268: 23116-23121.
5Liggett SB. Molecular and genetic basis of β2-adrenergic receptor function. J Allergy Clin Immunol, 1999, 103: S42-S46.
6Turki J, Lorenz JN, Green SA, et al. Myocardial signaling defects and impaired cardiac function of a human β2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci, 1996, 93:10483-10488.
7Liggett SB, Wagoner LE, Craft LL, et al. The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest, 1998, 102: 1534-1539.
8Wagoner LE, Craft LL, Singh B, et al. Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure.Circ Res, 2000, 86: 834-840.
9Huang WY, Xie CH, Zhou HY, et al. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients [J]. Eur J Heart Fail, 2004, 6 (1) :23-27.
10Pinto YM, van Gilst WH, Kingma JH, et al. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction [J].J Am Coll Cardiol, 1995,25 (6): 1622-1626.
6Rigat B.Hubert C,Corvol P,et al.PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).Nucleic Acids Res,1992,20:1433.
7Russ AP,Maeiz W,Ruzicka V,et al.Rapid detection of the hypertension associated Met23S Thr allele of the human angiotensinogen gene.Hum Mol Genet,1993,2:609-610.
8Gubaev KI,Nasibullin TR,Zakirova AN,et al.Association of polymorphic markers I/D of gene ACE and A1166C of ge-neAT2Rl with ischemic chronic heart failure in the Russian and Tatar populations of Bashkortostan republic.Cenetika,2006,42:1712-1717.
9Cuoco MA,Pereira AC,de Freitas HF,et al.Angiotensin converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure,int J Cardiol,2005,99:97-103.
10Fatini C,Sticchi E,Marcucci R,et al.ACE insertion/deletion,but not -240 A》T polymorphism,modulates the severity in heart failure.J Investig Med,2008,56:1004-1010.
